Company profile for EMD Serono

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the U.S. We have a long history of integrating cutting-edge science and innovative technology to develop products and devices that meet the needs of patients living with difficult-to-treat diseases. Today, our refocused pipeline is the strongest it has ever been, with more than 20 projects in clinical development focused on potential new oncolog...
At EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the U.S. We have a long history of integrating cutting-edge science and innovative technology to develop products and devices that meet the needs of patients living with difficult-to-treat diseases. Today, our refocused pipeline is the strongest it has ever been, with more than 20 projects in clinical development focused on potential new oncology and immuno-oncology medicines in more than 15 difficult-to-treat tumor types, as well as investigational treatments for psoriasis, lupus, multiple sclerosis, and other autoimmune diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
One Technology Place, Rockland, MA 02370
Telephone
Telephone
+18002838088
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251124788420/en/EMD-Serono-Takes-Patient-Directed-Approach-to-Bring-Innovation-to-the-Treatment-of-Rare-Neuromuscular-Disorder-Generalized-Myasthenia-Gravis

BUSINESSWIRE
24 Nov 2025

https://www.businesswire.com/news/home/20251017967416/en/Pimicotinib-Treatment-Demonstrates-Deep-and-Durable-Tumor-Responses-and-Continued-Improvements-in-Pain-and-Function-for-Patients-with-TGCT

BUSINESSWIRE
17 Oct 2025

https://www.fiercepharma.com/pharma/merck-kgaas-emd-serono-strikes-mfn-deal-trumps-fertility-treatment-pricing-push

FIERCE PHARMA
17 Oct 2025

https://www.biospace.com/policy/in-affordability-push-emd-serono-joins-trumprx-while-roche-launches-dtc-program

BIOSPACE
17 Oct 2025

https://www.pharmiweb.com/press-release/2025-10-16/emd-serono-announces-unprecedented-agreement-with-us-government-to-expand-access-to-ivf-therapies

PHARMIWEB
16 Oct 2025

https://www.businesswire.com/news/home/20250917584069/en/EMD-Serono-to-Present-New-Data-Highlighting-Durable-Effects-of-MAVENCLAD-in-Relapsing-Multiple-Sclerosis-RMS-at-ECTRIMS-2025

BUSINESSWIRE
17 Sep 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty